Veritas In Silico
Latest round
- Series C
Last raised
- Dec 2021
Total raised
- $37M
Investors
- 10
About Veritas In Silico
Veritas In Silico Inc. is a biotechnology firm focused on developing innovative low molecular weight drugs that target mRNA.Founded in 2016, Veritas In Silico Inc. is headquartered in Tokyo, Japan. The company specializes in drug development, particularly targeting mRNA therapies. Shingo Nakamura serves as both the Founder and CEO, guiding the company through its strategic initiatives.2 mn).Veritas In Silico specializes in the development of low molecular weight drugs that target mRNA, employing a proprietary platform for drug discovery utilizing artificial intelligence and computational methods. Their focus includes addressing diseases through mRNA-targeted therapies and enhancing existing treatments. The company collaborates with prominent pharmaceutical firms such as Takeda Pharmaceutical and Shionogi, emphasizing its capacity to engage in partnerships that expand its research capabilities.91 mn), generated mainly through partnerships and collaborative agreements with large pharmaceutical companies.2 mn) to support the advancement of new mRNA-targeted products and expand into additional geographical markets, particularly in the United States and Europe, by 2023. This approach is expected to solidify their position in the biopharmaceutical landscape while fostering long-term growth.
Who invested in Veritas In Silico
10 investors across 4 rounds
See all investors in Veritas In Silico
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Veritas In Silico
Who invested in Veritas In Silico?
Veritas In Silico has 10 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Veritas In Silico raised?
Veritas In Silico has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Veritas In Silico last raise money?
Veritas In Silico's most recent round on record is a Series C, in Dec 2021.
What does Veritas In Silico do?
Veritas In Silico is a pharmaceuticals company.
Where is Veritas In Silico headquartered?
Veritas In Silico is headquartered in Tokyo, Japan.
Which VCs invest in companies like Veritas In Silico?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Veritas In Silico's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Veritas In Silico? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.